Zacks Investment Research
10 Jun 2026, 22:50 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Top 2 movers · tap to explore
What the story claims
4 claims · each scored for market impact
Analysts expect Amgen to report a year-over-year earnings decline of 7.81% per share in its upcoming earnings disclosure. — Expected declines in earnings per share typically exert downward pressure on a stock's price ahead of reports.
-0.40Amgen's revenue is projected to increase by 2.87% year-over-year to $9.44 billion in the upcoming quarter. — Modest revenue growth provides a partial offset to declining earnings, suggesting some top-line resilience.
+0.20Amgen is trading at a Forward P/E ratio of 15.48, which is a discount compared to its industry average of 21.35. — Trading at a discount to peers can make a stock more attractive to value investors, providing a potential price floor.
+0.20Continue reading
6 related stories
Amgen currently holds a Zacks Rank of #3 (Hold). — A 'Hold' rating suggests a neutral near-term outlook with no strong conviction for price movement in either direction.
+0.00Which stocks this story touches
The stock closed down 2.05% and analysts expect a year-over-year earnings decline of 7.81%.
Go deeper
You just saw which tickers this one story hits. A free account turns that into a standing screen: the movers delivered on schedule, before the chart catches up.
On this page · free
In the platform
Free account, 30 seconds. No credit card.
Screener bridge
Catch the names this kind of story moves — before the chart does.
Get the full NIS Momentum results every Friday at 4PM ET — free via email or Telegram.
Zacks Investment Research
2h ago
